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A bs t r ac t

Background
Two inflammatory disorders, type 1 diabetes and celiac disease, cosegregate in populations, suggesting a common genetic origin. Since both diseases are associated with the HLA class II genes on chromosome 6p21, we tested whether non-HLA loci are shared.
Methods
We evaluated the association between type 1 diabetes and eight loci related to the risk of celiac disease by genotyping and statistical analyses of DNA samples from 8064 patients with type 1 diabetes, 9339 control subjects, and 2828 families providing 3064 parent-child trios (consisting of an affected child and both biologic parents). We also investigated 18 loci associated with type 1 diabetes in 2560 patients with celiac disease and 9339 control subjects.
Results
Three celiac disease loci -RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, and TAGAP on chromosome 6q25 -were associated with type 1 diabetes (P<1.00×10 −4 ). The 32-bp insertion-deletion variant on chromosome 3p21 was newly identified as a type 1 diabetes locus (P = 1.81×10 −8 ) and was also associated with celiac disease, along with PTPN2 on chromosome 18p11 and CTLA4 on chromosome 2q33, bringing the total number of loci with evidence of a shared association to seven, including SH2B3 on chromosome 12q24. The effects of the IL18RAP and TAGAP alleles confer protection in type 1 diabetes and susceptibility in celiac disease. Loci with distinct effects in the two diseases included INS on chromosome 11p15, IL2RA on chromosome 10p15, and PTPN22 on chromosome 1p13 in type 1 diabetes and IL12A on 3q25 and LPP on 3q28 in celiac disease.
Conclusions
T ype 1 diabetes is caused by autoimmune destruction of the insulin-producing beta cells in the pancreatic islets. The disease affects approximately 0.4% of persons of European origin and is strongly clustered in families. The major susceptibility genes -the HLA class II loci, HLA-DQB1 and HLA-DRB1 on chromosome 6p21 -act in combination with many other non-HLA loci across the genome, 1,2 with unknown environmental factors playing a major role. [3] [4] [5] [6] Celiac disease, which results from an immune, inflammatory reaction in the small intestine to proteins in ingested barley, wheat, and rye gluten, occurs in approximately 0.1% of persons of northern European origin, an estimate that is based on clinically diagnosed symptoms. However, within that population, the prevalence of celiac disease may be as high as 1% on the basis of the highly sensitive and specific test for autoantibodies to tissue transglutaminase. 7, 8 The major susceptibility gene is also HLA-DQB1. 9, 10 Celiac disease and anti-tissue transglutaminase antibodies occur more frequently in patients with type 1 diabetes than in the general population, depending on the age of the patient; at most, 10% of children and 2% of adults with type 1 diabetes have positive tests for such antibodies. 11 An increasing incidence of celiac disease during recent decades has also been reported. 8 It has been suggested that gluten consumption, along with gut permeability and inflammation, are factors in the development of type 1 diabetes. 6, 12 These results suggest that type 1 diabetes and celiac disease may share some causative genetic and environmental factors.
Genomewide association studies have recently identified eight chromosome regions outside the HLA region as being associated with celiac disease (P<5.00×10 −7 ), findings that probably provide a representative view of the major genetic effects in the northern European population for this disorder. 10 In patients with type 1 diabetes, 15 non-HLA regions have been established to date, 1, [13] [14] [15] and two other loci, IL7R on chromosome 5p13 and CD226 on chromosome 18q22, have been implicated in type 1 diabetes and multiple sclerosis. 1, 16, 17 It has already been reported that the SH2B3 locus on chromosome 12q24 is shared between type 1 diabetes and celiac disease, with indications of such sharing in IL2-IL21 on chromosome 4q27 and CCR3 on chromosome 3p21. 9, 10 In addition, there is some evidence for association of the established type 1 diabetes loci, CTLA4 on chromosome 2q33 9, 18 and PTPN22 on chromosome 1p13, 19 in celiac disease. In this study, we evaluated the association between all these loci and type 1 diabetes and celiac disease, including the CCR5 32-bp insertion-deletion variant that we report here as a type 1 diabetes locus, in order to assess the genetic similarities and differences between these two inflammatory disorders. (See the Glossary and the Methods section in the Supplementary Appendix, available with the full text of this article at www.nejm.org.)
Me thods
Study Subjects
In our study, patients with type 1 diabetes (www. childhood-diabetes.org.uk/grid.shtml) were under 16 years of age at the time of sample collection, with a mean age at diagnosis of 7.5 years (range, 0.5 to 16 The diagnosis of celiac disease was based on clinical symptoms, a current gluten-free diet, serologic analysis, a biopsy sample of the small intestine, and response to treatment. The mean age at diagnosis was 41.0 years (range, 3 months to 84 years); 75.1% of the patients were female. The Irish collection consisted of 416 patients with celiac disease and 957 control subjects, and the Dutch collection consisted of 507 patients with celiac disease and 888 control subjects. 10 All patients with type 1 diabetes or celiac disease, control subjects, and parent-child trio families reported their race as white. The relevant research ethics committees approved the study, and written informed consent was obtained from all study subjects or their parents or guardians.
Genotyping
We genotyped single-nucleotide polymorphisms (SNPs) from 8 celiac disease loci -RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, CCR3 on chromosome 3p21, IL12A on chromosome 3q25, LPP on chromosome 3q28, IL2-IL21 on chromosome 4q27, TAGAP on chromosome 6q25, and SH2B3 on chromosome 12q24 -and from 15 type 1 diabetes loci -PTPN22 on chromosome 1p13, IFIH1 on chromosome 2q24, CTLA4 on chromosome 2q33, IL2-IL21 on chromosome 4q27, BACH2 on chromosome 6q15, IL2RA (CD25) on chromosome 10p15, PRKCQ on chromosome 10p15, INS on chromosome 11p15, ERBB3 on chromosome 12q13, SH2B3 on chromosome 12q24, CTSH on chromosome 15q24, CLEC16A on chromosome 16p13, PTPN2 on chromosome 18p11, UBASH3A on chromosome 21q22, and C1QTNF6 on chromosome 22q13 (for all gene names, see the Glossary in the Supplementary Appendix). We also genotyped SNPs from IL7R on chromosome 5p13, CD226 on chromosome 18q22, and the 32-bp insertion-deletion variant in CCR5 on chromosome 3p21.
Statistical Analysis
In our study, P<1.00×10 −4 was determined to indicate statistical significance. This approach was conservative because established evidence needed to show that the two diseases being studied have a familial association (cosegregation), a clinical or epidemiologic association, or both and that they share some clinical and biologic phenotypes. 20, 21 We also required that the evidence for the locus association with the first disease be robust and convincing (i.e., P<5.00×10 −7 in multiple populations) and that there be robust marker scoring and statistical analyses (see the Supplementary Appendix for details).
R esult s
Celiac Disease Loci in Type 1 Diabetes
We genotyped samples from 8064 patients with type 1 diabetes and 9339 control subjects and, where appropriate, samples from 2828 families. We chose the nine SNPs with the highest disease association from the eight non-HLA regions associated with celiac disease 10 ( Table 1, and Table 1 in the Supplementary Appendix). Three of these newly analyzed regions -RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, and TAGAP on chromosome 6q25 -showed strong evidence of association with type 1 diabetes (P<1.00×10 −4 ) in case-control and family subjects. Therefore, along with the sharing in SH2B3 on chromosome 12q24 that was reported previously, 10 four of these eight celiac disease loci are shared with those associated with type 1 diabetes (Fig. 1A) . The celiac disease-associated SNPs rs6441961 in CCR3 and rs6822844 in IL2-IL21 did not reach the threshold for significance for type 1 diabetes (P>1.00×10 −4 ) ( Table 1 ). The regions IL12A on chromosome 3q25 and LPP on chromosome 3q28 showed no evidence of association with type 1 diabetes (P>0.15) ( Table 1 and Fig. 1D ).
Since the association for CCR3 in the type 1 diabetes case-control analysis (P = 3.40×10 −4 ) narrowly missed the threshold for significance and CCR3 is one of several chemokine receptor genes on chromosome 3p21, we hypothesized that a stronger association with type 1 diabetes might exist owing to a polymorphism in one of the other CCR genes in this region, all of which are functional candidates for both diseases. Therefore, we tested the association of two established functional variants, one in CCR2 (rs1799864, Ile64Val) and the other in CCR5 (rs333, the 32-bp insertion-deletion variant), which have been reported to be associated with susceptibility to infection with the human immunodeficiency virus (HIV) and with the outcome and treatment of HIV. 22 Moreover, polymorphisms of CCR5 and its ligand, CCL3L1, have also been associated with susceptibility to rheumatoid arthri tis 23,24 and with type 1 diabetes in several smaller studies in which the results remain uncon firmed. 25-28 We did not find any evidence for an association between rs1799864 in CCR2 and type 1 diabetes (odds ratio, 0.97; 95% confidence interval [CI], 0.89 to 1.06; P = 0.51) ( Table 2 in the Supplementary Appendix). In contrast, homozygosity of the rs333 32-bp insertion-deletion variant in CCR5, which encodes a nonfunctional receptor, was associated with a decreased risk of type 1 diabetes (odds ratio, 0.54; 95% CI, 0.40 to 0.72; P = 1.88×10 −6 with 2 df). We validated the association in the family collection (relative risk, 0.53; 95% CI, 0.34 to 0.82; P = 0.009; P = 1.81×10 −8 with 2 df for the overall comparison). The CCR5 insertion-dele- with replication evidence in one disease and P<0.05 in the other). Panel C shows SNPs with an association in type 1 diabetes but not in celiac disease. Panel D shows SNPs with an association in celiac disease but not in type 1 diabetes. Within each category, SNPs are ordered according to chromosome number. Odds ratios were estimated with the use of logistic regression (1-df trend model). For IL18RAP (second from the left on the graph), the odds ratio is for homozygous genotypes with 2 df. The tion, rs333, is located 62 kb centromeric from the rs6441961 SNP in CCR3 (D′ = 0.98, r 2 = 0.05), and logistic-regression analysis indicated that the potential association with type 1 diabetes with rs6441961 in CCR3 was not due to linkage disequilibrium with rs333 (rs333 added to rs6441961, P = 3.39×10 −5 ; in reverse analysis, rs6441961 added to rs333, P = 0.008).
Type 1 Diabetes Loci in Celiac Disease
We analyzed the associations of the 18 loci that have been associated with type 1 diabetes in celiac disease (including the CCR5 insertion-deletion, rs333, and the SH2B3 locus on 12q24 that was previously recognized to be shared between the two diseases) by genotyping 19 SNPs and the rs333 variant in CCR5 in 2560 patients with celiac disease. We then compared the results with those from 9339 control subjects (Table 2 and Fig. 1 , and Table 3 in the Supplementary Appendix). The loci with the most significant associations were CTLA4 (rs3087243) with an odds ratio of 0.85 (P = 1.26×10 −6 ) and CCR5 (rs333) with an odds ratio of 0.79 (P = 9.18×10 −6 ). The findings in these two regions indicated that these are probably true effects, a conclusion supported by previous reports that these loci have been associated with both type 1 diabetes and celiac disease and other immune-mediated diseases. 9, 18, [23] [24] [25] [26] [27] [28] Markers in CCR5 and CCR3 were independently associated with celiac disease (in logisticregression analysis, rs333 added to rs6441961, P = 0.001; in reverse analysis, rs6441961 added to rs333, P = 0.01). These results indicate that there are two or more causal variants or genes in this region of chromosome 3p21, which is rich in chemokine and chemokine receptor genes.
We previously reported two independent associations with type 1 diabetes within the PTPN2 region marked by the SNPs rs1893217 and rs478582. 1 Resequencing of the PTPN2 gene, genotyping, and analyses identified SNP rs45450798 in high linkage disequilibrium with rs1893217 (r 2 = 0.97), so rs45450798 replaces rs1893217 as the most strongly associated SNP in the PTPN2 region. Logistic forward regression analysis revealed that rs45450798 explained the association at rs1893217 and, combined with rs478582, explained the association with type 1 diabetes of the PTPN2 chromosome region (Table 4 in the Supplementary Appendix). In the patients with celiac disease, the significance of the association of PTPN2 SNP rs45450798 (P = 2.61×10 −4 ) narrowly missed the threshold of P<1.00×10 −4 (Table 2) . Therefore, we analyzed the available but unpublished data for the two independent case-control sample sets from Ireland and the Netherlands, obtaining consistent support for the association of PTPN2 rs1893217 with celiac disease (P = 0.045) ( Table 6 in the Supplementary Appendix). Given the fact that PTPN2 has also been associated with another inflammatory disorder, Crohn's disease, 29 it is highly likely that PTPN2 is also a celiac disease locus, bringing the total of non-HLA celiac disease loci from 8 to 11.
Six other regions showed nominal evidence of association with celiac disease (P<0.05). The most strongly associated SNP for the risk of type 1 diabetes in the IL2-IL21 region on chromosome 4q27, rs2069763 (a synonymous SNP in exon 1 of IL2), is weakly associated with celiac disease (P = 0.02), which indicates that although this region is linked to both diseases, the genetic variants are different. The remaining regions are IL7R on chromosome 5p13 (P = 0.007), BACH2 on chromosome 6q15 (P = 0.003), PRKCQ on chromosome 10p15 (P = 0.02), CD226 on chromosome 18q22 (P = 0.01), and UBASH3A on chromosome 21q22 (P = 0.009). Figure 1 illustrates the combined results of Tables 1 and 2 , with 15 loci showing some evidence for colocalization (assuming two susceptibility variants in the IL2-IL21 region on chromosome 4q27); of these, 7 have convincing evidence: RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, CTLA4 on chromosome 2q33, CCR5 on chromosome 3p21, TAGAP on chromosome 6q25, SH2B3 on chromosome 12q24, and PTPN2 on chromosome 18p11. At least five showed distinct differences -namely, a strong association in one disease and no or little evidence for association in the other disease (INS on chromosome 11p15, PTPN22 on chromosome 1p13, IL2RA on chromosome 10p15, LPP on chromosome 3q28, and IL12A on chromosome 3q25) (Fig. 1C  and 1D ).
Discussion
Our findings and those reported previously 1, 10, 14, 15 provide convincing evidence that 21 non-HLA loci are associated with type 1 diabetes and 11 non-HLA loci are associated with celiac disease. Of these loci, we have identified three celiac disease loci as having an association with type 1 diabetes (RGS1, IL18RAP, and TAGAP) and two type 1 diabetes loci as having an association with celiac disease (CCR5 and PTPN2). Furthermore, our results provide confirmation of the importance of the CTLA4 region on chromosome 2q33. Seven of these chromosome regions are shared between the two diseases, suggesting that for an investigation of shared loci in two diseases that are known to cosegregate, the previous odds of 1000:1 against there being a true association at any tested candidate gene 20,21 is too conservative (Supplementary Appendix).
Four alleles -RGS1 on chromosome 1q31, CTLA4 on chromosome 2q33, SH2B3 on chromosome 12q24, and PTPN2 on chromosome 18p11 -show the same direction of association in the two diseases, constituting evidence for shared causal variants. We know that this is not due to bias in ascertainment of the cases, nor is the use of a common set of control subjects a problem since we have consistent results from our familybased analyses (Supplementary Appendix).
The minor alleles of the SNPs rs917997 (IL18RAP on chromosome 2q12) and rs1738074 (TAGAP on chromosome 6q25) were negatively associated with type 1 diabetes, whereas these minor alleles were positively associated with celiac disease. 10 These results may be interpreted in two ways: the causal variants in these two regions may have opposite biologic effects in type 1 diabetes and celiac disease, or there may be different causal variants for each disease in each region with the typed marker SNPs tagging these causal variants. For the regions of IL18RAP on chromosome 2q12 and TAGAP on chromosome 6q25, we have found no evidence for a second locus within these regions in genomewide association studies of type 1 diabetes 13,15 (data not shown). Moreover, there is precedent for a causal variant having opposing effects in different diseases. For example, the minor allele of PTPN22 variant Arg620Trp on chromosome 1p13 predisposes a person to many immune-mediated diseases but is protective for Crohn's disease. 30 Hence, we favor the possibility that the causal variants have opposite effects in patients with type 1 diabetes and celiac disease. In contrast, for chromosome 4q27, our data indicate that different causal variants are involved in type 1 diabetes and celiac disease, perhaps affecting different genes. The important immune-response genes, IL-2 31 and IL-21, are strong functional candidates. Before we can draw further conclusions, all the regions discussed here must be thoroughly resequenced from multiple persons to ascertain a complete catalogue of polymorphisms, followed by further genotyping to identify all the variants with the most association.
Nevertheless, the 32-bp insertion-deletion in CCR5 (rs333), which causes a loss of expression of the receptor, 22 could well be the actual functional, causal variant involved. The disease associations of the two chemokine receptor genes, CCR3 and CCR5, suggest the central importance of lymphocyte trafficking in these organ-specific diseases. The development and anatomy of the small intestine and pancreas are close, and the gut immune system shares close connections with pancreatic lymph nodes, which have been linked to insulitis and destruction of beta cells. 32 In patients with recent-onset type 1 diabetes, alterations in levels of two CCR5 ligands, CCL3 (MIP-1α) and CCL4 (MIP-1β), have been reported. 33 In the NOD mouse model of type 1 diabetes, CCR5 and its ligand CCL4 have multiple reported roles in the development of disease. 34 However, there are distinct differences in genetic susceptibility between patients with type 1 diabetes and those with celiac disease, including differences in PTPN22 on chromosome 1p13, in IL2RA on chromosome 10p15, and in INS on chromosome 11p15. Although there are shared predisposing alleles at the HLA-DQB1 gene for type 1 diabetes and celiac disease, there are distinguishing differences in the HLA-DQB1 genotype (Supplementary Appendix). One possibility is that there is a common genetic background with respect to autoimmunity and inflammation and that further combinations of more diseasespecific variation at HLA and non-HLA genes, in interaction with epigenetic and environmental factors, determine the final clinical outcomes.
Our results support further evaluation of the hypothesis that cereal and gluten consumption might be an environmental factor in type 1 diabetes, leading to the alteration of the function of the gut immune system and its relationship with the pancreatic immune system. 6, 12, 32, 35 Furthermore, insulin and its precursors are major targets of the T and B lymphocyte autoreactive response except for rs333 in CCR5, rs45450798 in PTPN2, and rs12722495 in IL2RA (Tables 2, 4 , and 5 in the Supplementary Appendix). † The minor allele frequency was estimated in a maximum of 9339 control subjects, 8064 patients with type 1 diabetes, and 2560 patients with celiac disease. ‡ The 2-df test is reported for P values when there was a significant difference between the model for genotypic effects and that for multiplicative allelic effects so that the multiplicative model was not the appropriate one. § In the British case-control samples, rs3788013 is in complete linkage disequilibrium (r 2 = 1) with rs876498. 
